ACE and heart failure: Before enrolment, 49 (45%) participants were on a cardiac medication due to clinical signs and symptoms of heart failure in the peripartum time period (42 participants on furosemide, 14 on ACE-inhibitor, 10 on a beta-blocking agent, 4 on spironolactone, 4 on digoxin, and 5 on bromocriptine).